Pre-Eclampsia, Severe
30
3
4
15
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.7%
2 terminated out of 30 trials
88.2%
+1.7% vs benchmark
20%
6 trials in Phase 3/4
20%
3 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (30)
PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)
Biomarkers in Management of Post Partum Preeclampsia
Finger Plethysmography to Predict Fluid Responsiveness in Healthy Pregnancy and Severe Preeclampsia
LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention
Preeclampsia And Nonsteroidal Drugs for Analgesia: a Randomized Non Inferiority Trial
Preeclampsia Educational Program Study (PrEPS)
Assessment of Maternal and Fetal Serum Biomarkers in Women With Pre-eclampsia
Metformin and Esomeprazole in Preterm Pre-eclampsia
Optic Nerve Sheath Diameter in Pre-Eclamptic Parturient Receiving Magnesium Sulfate Combined With Dexmedetomidine
A Feasibility Study to Evaluate the Safety of the KNP-1000 Apheresis System in Severe Preeclampsia
Intravenous Labetalol Versus Hydralazine in Preeclampsia
Expanded NIPT for Pregnancy Complications
Prevalence of Blood Pressure Complications During Cesarean Section in Pre-eclamptic Patients (HOPE)
Nudge to Drive Transitions of Care
Postpartum Low-Dose Aspirin After Preeclampsia for Optimization of Cardiovascular Risk (PAPVASC)
The Use of Eculizumab in HELLP Syndrome
Nifedipine XL Versus Placebo for the Treatment of Preeclampsia With Severe Features During Induction of Labor
Transorbital Ultrasound of Optic Nerve Sheath Diameter Between Healthy Pregnant Women and Those With Severe Preeclampsia.
Metformin and Esomeprazole For Preterm Pre-eclampsia
Comparing Nifedipine and Enalapril in Medical Resources Used in the Postpartum Period